文献速递腹部CTUS

肝脏上皮样血管平滑肌脂肪瘤:超声造影与CT增强的临床特征及影像表现

Hepatic epithelioid angiomyolipoma: clinical features and imaging findings of contrast-enhanced ultrasound and CT.
PubMed 文献 · Clin Radiol · 2016-11-24

回顾2006年1月至2015年11月经病理证实的6例肝脏上皮样血管平滑肌脂肪瘤(EAML)患者,分析其临床特征及超声造影(CEUS)与CT增强(CECT)表现。6例均为女性,平均年龄43.5岁,无特异性症状,实验室检查正常。CEUS动脉期100%呈均匀高增强,延迟期67%(4/6)呈低增强;CECT动脉期100%(4/4)明显高增强,门脉期廓清。平均随访11.8个月无复发或转移。EAML强化方式与肝细胞癌相似,在无病毒性肝炎感染女性患者中应作为可能的鉴别诊断。

要点

  • 肝脏EAML好发于无病毒性肝炎感染女性,无特异性症状且实验室检查正常。
  • CEUS动脉期100%均匀高增强,延迟期67%(4/6)低增强;CECT动脉期100%(4/4)明显高增强,门脉期廓清。
  • 强化方式与肝细胞癌相似,无病毒性肝炎女性患者中应纳入鉴别诊断。

核心结论

  • 肝脏EAML的CEUS与CECT强化方式与肝细胞癌相似,在无病毒性肝炎感染女性患者中应作为可能的鉴别诊断。

研究设计与样本

  • 2006年1月至2015年11月期间,6例经组织病理学证实的肝脏EAML患者接受CECT和超声检查,其中6例行CEUS、4例有CECT图像,收集并分析患者人口学资料、临床表现、实验室检查结果及影像表现。

关键影像表现/征象

  • 常规超声显示50%肝脏EAML呈低回声,50%呈混合回声。
  • CEUS显示100%肝脏EAML动脉期呈均匀高增强,67%(4/6)延迟期呈低增强。
  • CECT显示100%(4/4)肿瘤动脉期明显高增强,门脉期廓清。

诊断标准与关键数值

  • CEUS动脉期均匀高增强者占100%,延迟期低增强者占67%(4/6)。
  • CECT动脉期明显高增强者占100%(4/4),门脉期廓清者占100%(4/4)。
  • 病灶最大径3.1至6.5 cm,平均4.4 cm。

临床应用与阅片要点

  • 肝脏EAML强化方式与肝细胞癌相似,在无病毒性肝炎感染女性患者中应作为可能的鉴别诊断。
  • CEUS动脉期均匀高增强、延迟期低增强(67%,4/6)与CECT动脉期明显高增强、门脉期廓清(100%,4/4)为观察到的强化模式。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the clinical features and imaging findings of epithelioid angiomyolipoma (EAML) on contrast-enhanced ultrasound (CEUS) and contrast-enhanced computed tomography (CECT).

MATERIALS AND METHODS: During January 2006 to November 2015, six patients with histopathologically proven hepatic EAML were evaluated using both CECT and ultrasonography. Six patients underwent CEUS and four patients had CECT images. Patients' demographics, clinical presentations, laboratory test results, and imaging appearances were collected and analysed.

RESULTS: Six patients were female, and the mean age was 43.5 years. All hepatic EAMLs were solitary. None of patients had specific symptoms, and laboratory tests were normal in all patients. The maximal diameter of the lesions ranged from 3.1 to 6.5 cm (mean 4.4 cm). Baseline ultrasound revealed that 50% of hepatic EAMLs were hypo-echoic and 50% were mixed echoic. CEUS showed that 100% of the hepatic EAMLs displayed homogeneous hyperenhancement in the arterial phase and 67% (4/6) showed hypo-enhancement in the late phase. On CECT, 100% (4/4) of the neoplasms were significantly hyperenhanced in the arterial phase and washout in the portal phase. There was no recurrence or metastasis after a mean follow-up period of 11.8 months.

CONCLUSION: Hepatic EAML shows similar enhancement patterns to that of hepatocellular carcinoma. It should be considered as a possible differential diagnosis in female patients without viral hepatitis infection.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Tan Y, Xie X, Lin Y, et al. Hepatic epithelioid angiomyolipoma: clinical features and imaging findings of contrast-enhanced ultrasound and CT. Clin Radiol. 2016. PMID: 27890423. doi:10.1016/j.crad.2016.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。